RMNI(RMNI)
RMNI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $443M | $468M |
| Low | $435M | $460M |
| High | $447M | $473M |
| EBITDA Avg | $85M | $90M |
| Low | $83M | $88M |
| High | $86M | $90M |
| EBIT Avg | $86M | $91M |
| Low | $85M | $89M |
| High | $87M | $92M |
| Net Income Avg | $31M | $42M |
| Low | $31M | $42M |
| High | $32M | $43M |
| EPS Avg | $0.33 | $0.45 |
| Low | $0.32 | $0.44 |
| High | $0.34 | $0.46 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $111M | $117M | $112M | $114M | $117M | $123M |
| Low | $110M | $116M | $111M | $114M | $116M | $122M |
| High | $111M | $118M | $112M | $115M | $118M | $124M |
| EBITDA Avg | $21M | $22M | $21M | $22M | $22M | $24M |
| Low | $21M | $22M | $21M | $22M | $22M | $23M |
| High | $21M | $22M | $21M | $22M | $22M | $24M |
| EBIT Avg | $22M | $23M | $22M | $22M | $23M | $24M |
| Low | $21M | $23M | $22M | $22M | $23M | $24M |
| High | $22M | $23M | $22M | $22M | $23M | $24M |
| Net Income Avg | $9M | $14M | $7M | $9M | $11M | $15M |
| Low | $8M | $14M | $7M | $9M | $11M | $15M |
| High | $9M | $15M | $7M | $9M | $11M | $15M |
| EPS Avg | $0.10 | $0.15 | $0.08 | $0.10 | $0.12 | $0.16 |
| Low | $0.09 | $0.15 | $0.08 | $0.10 | $0.12 | $0.16 |
| High | $0.10 | $0.15 | $0.08 | $0.10 | $0.12 | $0.16 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |